Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

U.S. Leadership

Content :

U.S. Leadership

Chad Hoover

Chief Commercial Officer, Sanofi Pasteur North America and General Manager, Sanofi Pasteur US


As Chief Commercial Officer, Sanofi Pasteur North America and General Manager, Sanofi Pasteur US, Chad Hoover directs the development and implementation of commercial strategies across U.S. and Canadian Commercial Operations to ensure sustainable growth and build on Sanofi Pasteur’s leadership position in the vaccines market.

Responsible for more than $3 billion in North American vaccine sales, Chad concentrates on guiding the specialized activities of each area under his leadership, including Sanofi Pasteur’s subsidiary business, VaxServe.

Chad has taken on roles of increasing responsibility during his 23 years with Sanofi Pasteur. Most recently, he served as Vice President and Chief Commercial Officer for the U.S.

Chad also demonstrates his commitment to vaccines through his co-leadership role with the Biotechnology Industry Organization’s (BIO) Vaccine Policy Advisory Committee.

He is a graduate of Montana State University, where he earned a bachelor of science degree.

Christopher Kaplan

North America Head, Diabetes & Cardiovascular Business Unit; Chair, U.S. Country Council


Christopher Kaplan is North America Head of the Diabetes & Cardiovascular Business Unit. In this role, he oversees all Diabetes and Cardiovascular business operations, including Sales, Marketing, Market Access and Integrated Care, across the U.S. and Canada with responsibility for key brands including Toujeo®, Lantus® and Praluent®.

Christopher serves as a member of Sanofi’s Global Senior Leadership Team, the Global Diabetes & Cardiovascular Leadership Team, and is Chair of the Sanofi U.S. Country Council. Christopher is also a Board Member for the National Pharmaceutical Council.

He joined Sanofi in January 2016 as Global Diabetes Franchise Head. Previously, Christopher held multiple executive leadership roles in several highly respected healthcare companies. He began his pharmaceutical career as a sales representative with Bristol Myers Squibb and progressed to roles in Sales and Marketing across the U.S., France and Italy.

During his 12 year tenure at Novartis, Christopher acted as the Global Head of the Cardiovascular & Metabolic Franchise, as well as in country and regional GM roles, demonstrating his leadership abilities in a variety of cultural contexts including Sweden and Switzerland. Upon returning to the U.S., he served as President of the Cardiovascular and Metabolic Operating Unit, and then concluded his time at Novartis as President & GM of the East Operating Unit. Prior to Novartis, Christopher was Senior Vice President and Chief Marketing Officer for Boehringer Ingelheim.

Christopher received his Bachelor of Arts from Columbia University and Masters of Science Degree from the University of Pennsylvania.

Jean-Paul Kress

North America Region Head, Multiple Sclerosis, Oncology and Immunology, Sanofi Genzyme


Jean-Paul Kress, MD serves as North America Region Head, Multiple Sclerosis, Oncology and Immunology for Sanofi Genzyme. In this role, he is responsible for overall strategy, sales, marketing, market access and public affairs across these three therapeutic areas. He is a member of the Executive Leadership Team.

Jean-Paul joined Sanofi in 2011 as President of Sanofi Pasteur MSD, a joint venture between Sanofi Pasteur and Merck & Co. He was actively involved in the development of health policy across the EU with a focus on disease prevention.

Prior to his work at Sanofi Pasteur MSD, Jean-Paul served as Vice President and General Manager in France for Gilead, a major US-based biopharmaceutical company. He joined Gilead in California in 2006 as Vice President, US Sales and Marketing. Prior to Gilead, Jean-Paul was at Abbott Laboratories for more than nine years.

Jean-Paul holds an MD Degree from Faculté Necker-Enfants Malades in Paris, France, and is an alumnus of the Ecole Normale Supérieure in Paris, France, where he did his post-graduate work in molecular and cellular pharmacology.

Robert Long

Chief Executive Officer, Chattem, Inc.; Head of Consumer Health Care North America


Robert Long is Chief Executive Officer of Chattem, Inc., and Head of Consumer Health Care North America.

Prior to this role, Robert served in various executive positions for the Company. Before joining Chattem, he was Chief Financial Officer for a Chattanooga-based hosiery manufacturer and served as a Senior Audit Manager with Ernst & Young, LLP, and Arthur Andersen, covering principally the Southeastern U.S.

Robert is a CPA and a member of the Tennessee Society of CPAs and American Institute of CPAs.

He earned his Bachelor of Science in Finance, with a Minor in Economics, from the University of Tennessee (Chattanooga).

Yann Mazabraud

US General Manager & NA Region Head for Rare Diseases, Sanofi Genzyme


Yann Mazabraud is the US General Manager and the North America Region Head for Rare Diseases for Sanofi Genzyme. In this role, he is responsible for the leadership, strategy and overall success of this business.

Yann joined Genzyme in 1999, and over the past 17 years, he has held roles of increasing responsibility within the company. He was hired as a Clinical Science Associate in France and spent 12 years with the French affiliate, where he held sales and marketing leadership roles in Rare Diseases, and served as the Business Unit Director for the Renal-Cardiovascular business.

In 2011, Yann joined Genzyme in Latin America as the Head of Rare Diseases and was promoted to Vice President, Head of Genzyme in Latin America in May 2014.

Prior to joining Genzyme, Yann worked in a consumer goods business in Germany and in a medical devices business in France.

Yann holds a master’s degree in business administration from the Ecole Superieure de Commerce de la Rochelle in France.

Last update: January 05, 2017